Chris Schulz Published

Marshall University Researchers Use Modern Technology To Advance Precision Medicine

A digital illustration of artificial intelligence. Pictured is the profile shape of a human face made out of computer code against a blue background.
G2PDeep is available to researchers, clinicians and public health professionals seeking to leverage multiomics data to drive discovery and innovation.
peshkova/Adobe Stock
Listen

Researchers from Marshall University have partnered with the University of Missouri to develop an AI platform to more accurately predict complex health outcomes.

The web-based platform G2PDeep can analyze multiple types of biological data including: gene expression, microRNA (miRNA) expression, protein expression, DNA methylation, single nucleotide polymorphisms (SNPs) and copy number variations (CNVs).

The team’s peer-reviewed article describing the technology was published this month in Biomolecules. The researchers expect the AI to have wide-reaching biomedical applications including cancer, addiction, aging, obesity, kidney disease and other conditions that significantly impact populations across Appalachia and the Midwest. 

“This collaboration demonstrates the power of academic partnerships in accelerating breakthroughs that can transform patient care,” said Trupti Joshi, professor and senior associate dean for informatics and population analytics at the Marshall University Joan C. Edwards School of Medicine and corresponding author on the study. “G2PDeep equips researchers with an accessible, sophisticated tool to better understand and address the health challenges facing our communities.”

G2PDeep is available to researchers, clinicians and public health professionals seeking to leverage multiomics data to drive discovery and innovation.